Sabha MacManus
Associate General Counsel, UK Serious Fraud Office (London, England)
[email protected] | 973-642-8382 or 973-761-9000 ext. 8382
PROGRAM SCHEDULED for October 10, 2025 | In-Person/Hybrid
PROGRAM SCHEDULED for June 5, 2026 | Virtual
All times are in Eastern Standard Time.
9:00 - 9:05
Welcome & Format Review
9:05 - 10:05
International Anti-Corruption Enforcement
Sabha MacManus
Associate General Counsel, UK Serious Fraud Office (London, England)
Albert B. Stieglitz, Jr.
Partner, Alston & Bird LLP (Washington, D.C.)
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
10:05 - 10:20
Break
10:20 - 11:20
Compliance-Specific Takeaways in Terms of Enforcement Priorities
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings LLP
Timothy Roberts
Global Chief Compliance Officer, Legend Biotech
Brian Howe
Sanofi
Charles Graybow
Pfizer
11:25 - 12:25
Third Party Arrangements
Laura Perkins
Partner, Hughes Hubbard & Reed LLP
12:20 - 1:20
Lunch Break
1:20 - 2:20
Case Study: Leading Positive Change Under a Deferred Prosecution Agreement Monitorship
David Walk
U.S. Attorney's Office, District of New Jersey
Gregory Paw
Partner, Freeh, Sporkin & Sullivan
Christine Gordon
Chief Compliance Officer, Olympus Corporation of the Americas
Christina Hud
Senior Compliance Counsel, Global Investigations, Pfizer
2:25 - 3:45
Practical Application Case Study
Wendy Tsuei
Head of Global Privacy, SpringWorks Therapeutics Inc.
3:45
Program Close
